We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

225 hedge funds and large institutions have $504M invested in Editas Medicine in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more call options, than puts

Call options by funds: $5.57M | Put options by funds: $2.71M

14% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 63

9.48% more ownership

Funds ownership: 73.56% → 83.04% (+9.5%)

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

0% more funds holding

Funds holding: 225 → 225 (0)

17% less capital invested

Capital invested by funds: $609M → $504M (-$105M)

Holders
225
Holders Change
–
Holders Change %
0%
% of All Funds
3.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
72
Reduced
63
Closed
35
Calls
$5.57M
Puts
$2.71M
Net Calls
+$2.86M
Net Calls Change
-$1.01M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$30.7M
2
Goldman Sachs
Goldman Sachs
New York
+$7.04M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$5.5M
4
Millennium Management
Millennium Management
New York
+$5.37M
5
Citigroup
Citigroup
New York
+$4.5M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$6.19M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.88M
3
Voloridge Investment Management
Voloridge Investment Management
Florida
-$4.27M
4
Marshall Wace
Marshall Wace
United Kingdom
-$2.66M
5
CSS
Cubist Systematic Strategies
Connecticut
-$2.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
BHWM
201
Beaird Harris Wealth Management
Texas
$594 – – –
CFGS
202
Concourse Financial Group Securities
Alabama
$556 – – –
KFI
203
Key Financial Inc
Pennsylvania
$556 – – –
MBFW
204
Morton Brown Family Wealth
Pennsylvania
$482 – – –
TC
205
Truvestments Capital
Florida
$453 – – –
GWP
206
Gen-Wealth Partners
Michigan
$393 +$440 +53 New
CFFP
207
Center for Financial Planning
Michigan
$371 – – –
NRG
208
Nemes Rush Group
Michigan
$371 – – –
First Manhattan
209
First Manhattan
New York
$319 – – –
CFD
210
Creative Financial Designs
Indiana
$297 – – –
NSIM
211
North Star Investment Management
Illinois
$282 – – –
CTA
212
Colonial Trust Advisors
South Carolina
$223 – – –
NC
213
NewSquare Capital
Pennsylvania
$223 – – –
HIA
214
Harbor Investment Advisory
Maryland
$148 – – –
CA
215
Clearstead Advisors
Ohio
$143 – – –
AWM
216
Avior Wealth Management
Nebraska
$126 +$141 +17 New
RIL
217
Rothschild Investment LLC
Illinois
$111 +$125 +15 New
AFWM
218
Abich Financial Wealth Management
Virginia
$89 – – –
MA
219
MCF Advisors
Kentucky
$82 +$91 +11 New
FFA
220
Farther Finance Advisors
California
$73 -$8 -1 -9%
Northwestern Mutual Wealth Management
221
Northwestern Mutual Wealth Management
Wisconsin
$59 +$58 +7 +700%
FP
222
Financial Perspectives
Minnesota
$45 – – –
GWSG
223
GPS Wealth Strategies Group
Colorado
$45 +$50 +6 New
SN
224
Sittner & Nelson
Oregon
$45 +$50 +6 New
Point72 Asset Management
225
Point72 Asset Management
Connecticut
– -$5.88M -579,967 Closed
7 8
9
10 11

EDIT Hedge Fund Activity: Q1 2024 in Review

225 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2024, worth a combined $504M — down 17% from $609M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new EDIT positions and 35 closed out — a net gain of 3 holders — while 72 added to existing stakes and 63 trimmed.

The largest buyer was State Street, adding an estimated $30.7M. The largest seller was Morgan Stanley, cutting an estimated $6.19M.

  • 225 institutional investors held Editas Medicine (EDIT) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $504M of Editas Medicine stock for Q1 2024, down 17% quarter-over-quarter.
  • 38 funds opened new Editas Medicine positions in Q1 2024 and 35 closed out, a net change of +3 holders.
  • The largest Editas Medicine buyer in Q1 2024 was State Street, an estimated $30.7M added.
  • The largest Editas Medicine seller in Q1 2024 was Morgan Stanley, an estimated $6.19M sold.

Based on aggregated 13F filings for Q1 2024.